{"title":"How Do Natalizumab and Fingolimod Compare With Injectable Disease-modifying Therapies for Pediatric-onset MS?","authors":"Dawn Fallik","doi":"10.1097/01.nt.0001010860.98433.9d","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":19197,"journal":{"name":"Neurology Today","volume":"56 s194","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology Today","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.nt.0001010860.98433.9d","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
